|
Real-time Estimate
Cboe Europe
03:50:29 2026-10-23 EDT
|
5-day change | 1st Jan Change | ||
| 127.26 CHF | -1.26% |
|
+2.41% | +16.51% |
| 10-22 | AbbVie's skin disease drug reduces lesions in trial, company eyes weight-loss combination | RE |
| 10-22 | Pharma sector doubles down on AI to slash costs, timelines | RE |
| Market Cap | 297B 266B 245B 223B 418B 28,178B 424B 2,951B 1,162B 14,763B 1,117B 1,093B 46,768B | P/E 2026 * |
21.9x | P/E 2027 * | 18.4x |
|---|---|---|---|---|---|
| Enterprise Value | 329B 294B 271B 246B 462B 31,176B 469B 3,265B 1,286B 16,333B 1,235B 1,209B 51,743B | EV / Sales 2026 * |
5.71x | EV / Sales 2027 * | 5.32x |
| Free-Float |
91.66% | Yield 2026 * |
2.79% | Yield 2027 * | 2.91% |
| Markets | Quality | ||
|---|---|---|---|
Swiss Exchange
| NOVN | Delayed | |
Borsa Italiana
| 1NOVN | End-of-day quote | |
|
CBOE
| 0QLR | Real-time | |
|
Xetra
| NOT | End-of-day quote | |
|
OTC Markets
| NVSEF | Delayed | |
|
Deutsche Boerse AG
| NOT | End-of-day quote | |
|
Xetra
| NOT | Delayed | |
|
Tradegate
| NOT | Real-time | |
|
Boerse Muenchen
| NOT | Real-time | |
|
London S.E.
| 0QLR | Delayed | |
|
Mexican S.E.
| NOVN N | End-of-day quote | |
|
CBOE
| Real-time | ||
|
CBOE
| 0QLR | Real-time | |
|
Börse Stuttgart
| NOT | Delayed | |
|
Deutsche Boerse AG
| NOT | Delayed | |
|
Wiener Boerse
| NOVN | End-of-day quote |
Last Transcript: Novartis AG
| 1 day | -1.20% | ||
| 1 week | +2.41% | ||
| Current month | +6.45% | ||
| 1 month | +8.59% | ||
| 3 months | +0.03% | ||
| 6 months | +9.82% | ||
| Current year | +16.51% |
| 1 week | 123.64 |  | 129.34 |
| 1 month | 115.94 | | 129.34 |
| Current year | 107.68 | | 132.68 |
| 1 year | 97.05 | | 132.68 |
| 3 years | 81.1 | | 132.68 |
| 5 years | 72.84 | | 132.68 |
| 10 years | 65.09 | | 132.68 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 50 | 2018-01-31 | |
Mukul Mehta
DFI | Director of Finance/CFO | - | 2026-03-15 |
Karen Hale
CMP | Compliance Officer | 58 | 2025-04-13 |
| Director | Title | Age | Since |
|---|---|---|---|
Nancy Andrews
BRD | Director/Board Member | 67 | 2014-12-31 |
| Director/Board Member | 69 | 2015-12-31 | |
Ton Büchner
BRD | Director/Board Member | 61 | 2015-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 5/18/26 | Sell | -5,200 | 0.0003% | |||
| 5/4/26 | Sell | 6,800 | 0.0003% | |||
| 2/17/26 | Sell | 30,743 | 0.0015% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.26% | +2.41% | +22.18% | +51.12% | 297B | |
| +2.83% | +4.40% | +60.84% | +123.50% | 1,165B | |
| +3.81% | +5.66% | +38.70% | +74.91% | 645B | |
| +0.14% | +0.63% | +24.71% | +95.03% | 504B | |
| -0.69% | +2.87% | +43.63% | +64.22% | 380B | |
| -1.76% | +1.41% | +68.06% | +43.41% | 363B | |
| -1.53% | +2.99% | +2.58% | +26.91% | 269B | |
| +2.04% | +3.05% | +51.12% | +60.42% | 237B | |
| +2.36% | -0.11% | +29.42% | +102.04% | 195B | |
| -0.40% | +1.66% | -23.06% | -61.32% | 175B | |
| Average | +0.76% | +2.20% | +31.82% | +58.03% | 423.09B | |
| Weighted average by Cap. | +1.35% | +2.58% | +40.34% | +77.08% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 57.64B 51.45B 47.47B 43.13B 80.91B 5,460B 82.15B 572B 225B 2,861B 216B 212B 9,063B | 61.32B 54.73B 50.49B 45.87B 86.06B 5,808B 87.38B 608B 240B 3,043B 230B 225B 9,640B |
| Net income | 14.34B 12.8B 11.81B 10.73B 20.12B 1,358B 20.43B 142B 56.02B 711B 53.81B 52.66B 2,254B | 15.94B 14.23B 13.12B 11.92B 22.37B 1,510B 22.71B 158B 62.28B 791B 59.82B 58.54B 2,506B |
| Net Debt | 31.64B 28.24B 26.06B 23.67B 44.41B 2,997B 45.09B 314B 124B 1,570B 119B 116B 4,975B | 28.7B 25.62B 23.63B 21.47B 40.28B 2,718B 40.9B 285B 112B 1,424B 108B 105B 4,512B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-23 | CHF 127.72 | -0.90% | 460,125 |
| 26-10-22 | CHF 128.88 | +1.58% | 3,387,898 |
| 26-10-21 | CHF 126.88 | +0.30% | 2,940,668 |
| 26-10-20 | CHF 126.50 | +1.85% | 3,198,959 |
| 26-10-19 | CHF 124.20 | -0.40% | 2,837,515 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- NOVN Stock
Select your edition
All financial news and data tailored to specific country editions
